Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: Findings from the Women and Infants Transmission Study

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 567-575

  Pitt, Jane ^a   Brambilla, Donald ^b   Reichelderfer, Pat ^b   Landay, Alan ^b   McIntosh, Kenneth ^b   Burns, David ^b   Hillyer, George V ^b   Mendez, Hermann ^b   Fowler, Mary Glenn ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MOTHER CHILD RELATION; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE; VIRUS TRANSMISSION;

EID: 0031017125     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.567     Document Type: Article

References (15)

1. Blanche S, Rouzioux C, Moscato MLF. A retrospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-8.
2. Goedert J, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet 1989;2:1351-4.
3. Report of a consensus workshop, Siena, Italy, January 17-18, 1992. Maternal factors involved in mother to child transmission of HIV-1. J Acquir Immune Defic Syndr 1992;5:1019-29.
4. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
5. St. Louis E, Kamenga M, Brown C. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2853-9.
6. Tibaldi C, Paloma E, Ziarati N. Maternal factors influencing vertical HIV transmission [abstract WC3277]. In: Program and abstracts: VII International Conference on AIDS (Florence, Italy). Rome: Istituto Superiore di Sanitá, 1991.
7. Weiser B, Nachman S, Tropper P, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother child-child transmission and stability of viral load. Proc Natl Acad Sci USA 1994;91:8037-41.
8. Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;92: 12100-4.
9. Dickover R, Garratty E, Herman S, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
10. Venet A, Lu W, Beldjord K, Andrieu JM. Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1-seropositive individuals. AIDS 1991;5:283-8.
11. Corey L, Coombs R. The natural history of HIV infection: implications for the assessment of antiretroviral therapy. Clin Infect Dis 1993; 16(suppl):S2-6.
12. Fiscus SA, DeGruttola V, Gupta P, et al. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter trial. J Infect Dis 1995;171:305-11.
13. Calvelli T, Denny T, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping; a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993; 14:702-15.
14. Landay AL, Brambilla D, Pitt J, et al. Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. Clin Diagn Lab Immunol 1995;2:462-8.
15. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis 1994;170:996-1000.